A Study to Determine the Effect of Triheptanoin Compared With Even-Chain MCT on MCEs in Pediatric Patients With LC-FAOD
Clinical trial NCT05933200 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05933200
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-28
- Primary completion
- 2027-08-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.